Inflammatory bowel disease (IBD) impacts 1.6 million people in the U.S. — and a new artificial intelligence-generated drug could help…
Browsing: Hot headlines in GI
Medicare Advantage (MA) payments are set to decrease yet again in 2025 as the feds phase in significant changes to…
Atlantic, Iowa-based Cass Health has partnered with Omaha, Neb.-based Midwest Gastrointestinal Associates to bring two GI specialists to Cass, according…
Faced with an opportunity to advocate for patients, Rajeev Jain, MD, AGAF, is never afraid to speak up. He recently…
Measuring disease status in inflammatory bowel disease (IBD) patients generally requires invasive blood draws or procedures, but a novel wearable…
Delfi Diagnostics has put forward a new cancer monitoring test that searches the blood for broken pieces of tumor DNA,…
Systematic implementation of a digital risk assessment tool can identify patients with high-risk cancer susceptibility syndromes and other actionable variants,…
An initiative at the University of North Carolina health system successfully increased the use of biosimilars in rheumatology and gastroenterology…
Motus GI Holdings, Inc. has announced positive results from a study of its second-generation Pure-Vu System, a bowel cleansing system…
TOPLINE:Biomarker testing completion rates in patients with metastatic colorectal cancer (CRC) has increased over time in alignment with guidelines and…